You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Details for Patent: 7,547,452


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,547,452
Title:Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
Abstract: Sustained-release microparticle composition. The microparticle composition can be formulated to provide extended release over a period of from about 7 days to about 200 days. The microparticles may be formulated with a biodegradable and biocompatible polymer, and an active agent, such as risperidone, 9-hydroxy-risperidone, and pharmaceutically acceptable acid addition salts of the foregoing.
Inventor(s): Atkins; Thomas J. (York, PA), Rickey; Michael E. (Loveland, OH), Mesens; Jean (Wechelderzande, BE)
Assignee: Alkermes, Inc. (Cambridge, MA) Janssen Pharmaceutica, N.V (Beerse, BE)
Application Number:11/826,384
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,547,452: A Detailed Analysis

Introduction

Patent 7,547,452, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To fully comprehend this patent, it is essential to delve into its various components and the broader patent landscape in the United States.

Patent Overview

What is Patent 7,547,452? Patent 7,547,452 is a utility patent granted by the United States Patent and Trademark Office (USPTO). Utility patents are the most common type of patent and are granted for new and useful processes, machines, manufactures, or compositions of matter, or any improvement thereof[4].

The Claims

Importance of Claims The claims section of a patent is crucial as it defines the scope of the invention and what is protected by the patent. Claims are the legal boundaries that distinguish the invention from prior art and other existing technologies[4].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive.
  • Dependent Claims: These claims refer back to and further limit an independent claim. They are narrower and often specify additional features or limitations of the invention[4].

Patent Scope

Measuring Patent Scope The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in understanding the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Subject Matter Eligibility

Section 101 of the Patent Act For a patent to be granted, the invention must meet the subject matter eligibility criteria under Section 101 of the Patent Act. This involves determining whether the claimed invention falls within one of the four statutory categories: processes, machines, manufactures, or compositions of matter. Additionally, the invention must not be a judicial exception (e.g., abstract ideas, natural phenomena, laws of nature) unless it integrates the exception into a practical application[4].

Recent Guidance on AI Patents

2024 USPTO Guidance Update The recent USPTO guidance update, effective July 17, 2024, provides significant insights into the patent eligibility of AI-related inventions. This update emphasizes the importance of evaluating whether a claim integrates a judicial exception into a practical application. For AI-assisted inventions, the focus remains on the claimed invention itself, rather than the method of invention development. This ensures that AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution[1].

Examples and Case Law

Practical Applications The 2024 guidance includes new examples specifically tailored to AI technologies. For instance, Example 48 illustrates how claims involving the use of separated audio components in a speech recognition system can meet the eligibility criteria by demonstrating a practical application. This example highlights that specifying the use of the separated audio in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments adds a level of practical utility, making the claim patent-eligible[1].

Inventorship

Determining True and Only Inventors Inventorship is a critical aspect of patent law. The true and only inventors must be listed in the patent application. This involves identifying those who conceived the idea and reduced it to practice. The Court of Appeals for the Federal Circuit has frequently addressed the question of proper inventorship, emphasizing the importance of correctly determining who should be listed as an inventor[2].

Patent Prosecution

Responding to Section 101 Rejections During the patent prosecution process, applicants often face Section 101 rejections. To overcome these rejections, it is essential to analyze and respond effectively. This involves proving that the claimed invention integrates a judicial exception into a practical application and demonstrating an inventive concept that goes beyond conventional elements[4].

Real-World Applications

Bolstering Patent Eligibility Highlighting the real-world applications of the claimed method or system can significantly bolster the argument for patent eligibility. Demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field is crucial. This approach ensures that the claimed invention offers a tangible outcome that directly benefits the technology[1].

Statistical Insights

Patent Scope and Examination Process Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. This underscores the importance of crafting claims that are clear, specific, and limited to the essential features of the invention[3].

Conclusion

Understanding the scope and claims of a patent like 7,547,452 requires a deep dive into the patent's components and the broader legal and regulatory framework. By focusing on practical applications, integrating judicial exceptions, and ensuring proper inventorship, inventors and patent practitioners can navigate the complex landscape of patent law effectively.

Key Takeaways

  • Claims Define the Invention: The claims section is critical in defining what is protected by the patent.
  • Subject Matter Eligibility: Inventions must meet the criteria under Section 101 of the Patent Act.
  • Practical Applications: Highlighting real-world applications can bolster patent eligibility.
  • Inventorship: Correctly determining the true and only inventors is essential.
  • Patent Scope Metrics: Independent claim length and count can measure patent scope.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The primary purpose of the claims section is to define the scope of the invention and what is protected by the patent.

Q: How does the 2024 USPTO guidance update impact AI-related inventions? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on the claimed invention itself rather than the method of development.

Q: What are the key metrics for measuring patent scope? A: Key metrics include independent claim length and independent claim count.

Q: Why is inventorship important in patent law? A: Correctly determining the true and only inventors is crucial to ensure that the patent application lists the rightful inventors.

Q: How can real-world applications impact patent eligibility? A: Highlighting real-world applications can demonstrate that the claimed invention provides concrete benefits, thereby bolstering the argument for patent eligibility.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims and Patent Scope - SSRN
  4. Patent Law in the United States - BitLaw
  5. U.S. Patent and Trademark Office (USPTO) - USA.gov

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,547,452

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 7,547,452

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 694147 ⤷  Try for Free
Australia 8142594 ⤷  Try for Free
Austria 288270 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.